Multiomics Analysis of the PHLDA Gene Family in Different Cancers and Their Clinical Prognostic Value
Current Issues in Molecular Biology, ISSN: 1467-3045, Vol: 46, Issue: 6, Page: 5488-5510
2024
- 1Citations
- 6Usage
- 1Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations1
- Citation Indexes1
- Usage6
- Downloads6
- Captures1
- Readers1
- Mentions1
- News Mentions1
- News1
Most Recent News
Research from Kyung Hee University Yields New Data on Cancer (Multiomics Analysis of the PHLDA Gene Family in Different Cancers and Their Clinical Prognostic Value)
2024 JUL 10 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Daily -- Investigators publish new report on cancer. According to news reporting
Article Description
The PHLDA (pleckstrin homology-like domain family) gene family is popularly known as a potential biomarker for cancer identification, and members of the PHLDA family have become considered potentially viable targets for cancer treatments. The PHLDA gene family consists of PHLDA1, PHLDA2, and PHLDA3. The predictive significance of PHLDA genes in cancer remains unclear. To determine the role of pleckstrin as a prognostic biomarker in human cancers, we conducted a systematic multiomics investigation. Through various survival analyses, pleckstrin expression was evaluated, and their predictive significance in human tumors was discovered using a variety of online platforms. By analyzing the protein–protein interactions, we also chose a collection of well-known functional protein partners for pleckstrin. Investigations were also carried out on the relationship between pleckstrins and other cancers regarding mutations and copy number alterations. The cumulative impact of pleckstrin and their associated genes on various cancers, Gene Ontology (GO), and pathway analyses were used for their evaluation. Thus, the expression profiles of PHLDA family members and their prognosis in various cancers may be revealed by this study. During this multiomics analysis, we found that among the PHLDA family, PHLDA1 may be a therapeutic target for several cancers, including kidney, colon, and brain cancer, while PHLDA2 can be a therapeutic target for cancers of the colon, esophagus, and pancreas. Additionally, PHLDA3 may be a useful therapeutic target for ovarian, renal, and gastric cancer.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85196873720&origin=inward; http://dx.doi.org/10.3390/cimb46060328; http://www.ncbi.nlm.nih.gov/pubmed/38921000; https://www.mdpi.com/1467-3045/46/6/328; https://digitalcommons.library.tmc.edu/uthgsbs_docs/1994; https://digitalcommons.library.tmc.edu/cgi/viewcontent.cgi?article=2942&context=uthgsbs_docs; https://dx.doi.org/10.3390/cimb46060328
MDPI AG
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know